Metraipolis › archive › dc_4eaad9011017

Cell secretome as a potential anticancer therapeutic agent: composition, mechanisms, preclinical evidence, and translational challenges — Europe PMC PMID:41858371

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41858371
DOI
10.3389/fonc.2026.1729022
License (as archived)
solo-consultazione
Archived
2026-11-05T03:14:23.919Z
SHA-256 of the archived text
fcc99a793915b091781327ae46416a34eae2d581e259cf82e69b9b58eaa872fc
Stable URL of this page
https://metraipolis.com/documento/dc_4eaad9011017

How to cite

Cell secretome as a potential anticancer therapeutic agent: composition, mechanisms, preclinical evidence, and translational challenges — Europe PMC PMID:41858371 — Europe PMC (en), https://europepmc.org/article/MED/41858371 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_4eaad9011017 (Metraipolis archive dc_4eaad9011017, sha256 fcc99a793915b091781327ae46416a34eae2d581e259cf82e69b9b58eaa872fc)
BibTeX
@misc{dc4eaad9011017,
  title = {Cell secretome as a potential anticancer therapeutic agent: composition, mechanisms, preclinical evidence, and translational challenges — Europe PMC PMID:41858371},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41858371},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_4eaad9011017; sha256 fcc99a793915b091781327ae46416a34eae2d581e259cf82e69b9b58eaa872fc},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41858371. Agents can read the archived copy with the MCP tool read_document.